Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.2339003219940552e-70,122.41033138401559,19704.486077823334,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.392685146298836e-68,0,0,78
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.8375366123375505e-45,43.80253104106972,4492.97422644547,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'UCP3', 'COX11', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",5.05081516996084e-43,0,0,57
3,Oxidative phosphorylation WP623,4.982280733328183e-25,36.041044776119406,2016.8114380998604,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",5.912306470216111e-23,0,0,32
4,Nonalcoholic fatty liver disease WP4396,1.804679177593754e-21,7.8305479338155815,374.0175407008643,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.606164468058441e-19,0,0,49
5,Mitochondrial complex I assembly model OXPHOS system WP4324,7.280995417360163e-21,27.924824452705494,1294.8467258636563,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'TMEM126B']",5.184068737160436e-19,0,0,28
6,Mitochondrial CIV Assembly WP4922,1.4190234808361533e-18,49.11876155268022,2018.612265290975,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",8.419539319627844e-17,0,0,22
7,Cellular Proteostasis WP4918,1.1453385583320746e-06,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",5.824864668088836e-05,0,0,6
8,Mitochondrial complex III assembly WP4921,1.4783468709576445e-06,23.51338199513382,315.6574204740989,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",6.578643575761518e-05,0,0,8
9,Pyrimidine metabolism WP4022,0.0001198970207772086,3.6849556167737987,33.27101228120638,"['POLR3GL', 'NME2', 'NME3', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLE3', 'TK1', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'POLR2L']",0.0047425932662984735,0,0,15
10,mRNA Processing WP411,0.0003022696956060852,3.315082644628099,26.866062625532603,"['DHX8', 'CELF1', 'NCBP2', 'CELF2', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.010760801163576634,0,0,15
11,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0013896105012723029,17.572727272727274,115.60625947613535,"['COX8A', 'CYP2C8', 'GSTP1', 'COX5A']",0.044972848950267263,0,0,4
12,Proteasome Degradation WP183,0.00890596770617603,3.2000663570006638,15.107621107761693,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'PSMB10', 'PSMA7']",0.2642103752832222,0,0,8
13,Nucleotide Excision Repair WP4753,0.010710398318745599,3.4205915122050037,15.517650916309906,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.2783901505840213,0,0,7
14,Ciliary landscape WP4352,0.01094792727015814,1.8550969529085872,8.375030222166336,"['RALB', 'DYNLT1', 'NDUFA5', 'SSNA1', 'EXOC6B', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'EHBP1', 'PSMD8', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'TMED1', 'EXOC6', 'SNRPB2', 'DCAF11', 'GLA']",0.2783901505840213,0,0,21
15,Base Excision Repair WP4752,0.024297477147154748,3.660524719441917,13.607571466781053,"['POLE4', 'POLD4', 'NTHL1', 'APEX1', 'POLE3']",0.5766601242924727,0,0,5
16,Heme Biosynthesis WP561,0.029342990093407986,17.542649727767696,61.90277615593315,"['UROD', 'HMBS']",0.614476733720779,0,0,2
17,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.029342990093407986,17.542649727767696,61.90277615593315,"['ELOB', 'ELOC']",0.614476733720779,0,0,2
18,DNA Repair Pathways Full Network WP4946,0.035380491214021904,2.0167924672156143,6.7393030323561565,"['POLE4', 'POLD4', 'DCLRE1C', 'CENPX', 'NTHL1', 'RFC2', 'APEX1', 'POLE3', 'RAD23A', 'MNAT1', 'GTF2H5']",0.6574118694660408,0,0,11
19,DNA Mismatch Repair WP531,0.03690137635453314,3.902222222222222,12.875407309805652,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.6574118694660408,0,0,4
20,Sleep regulation WP3591,0.036933251093597796,2.7748058671268336,9.1530940055839,"['CACNA1I', 'AHCY', 'STAR', 'CRH', 'BTBD9', 'HCRTR1']",0.6574118694660408,0,0,6
21,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.040552522311712545,5.265395095367848,16.876419515965463,"['EIF2S2', 'EIF3D', 'EIF1']",0.6874618068080793,0,0,3
22,Eukaryotic Transcription Initiation WP405,0.0471157898370152,2.927509857446163,8.943973231991876,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2J', 'POLR2K']",0.7624191446353369,0,0,5
23,Pilocytic astrocytoma WP2253,0.05471885264808473,8.770417422867514,25.48285980001248,"['NF1', 'BRAF']",0.8469526757703549,0,0,2
24,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.07446728712784274,3.760217983651226,9.766772701901427,"['RRAS2', 'BRAF', 'HRAS']",0.999860981724991,0,0,3
25,Peroxiredoxin 2 induced ovarian failure WP4873,0.08509040926321872,5.8463399879007865,14.405621134089069,"['STAR', 'BAX']",0.999860981724991,0,0,2
26,Mitochondrial CII Assembly WP4920,0.1024971932445951,inf,inf,['SDHAF1'],0.999860981724991,0,0,1
27,TCA cycle in senescence WP5050,0.11916885777767305,4.3843012704174225,9.326346247950024,"['ME1', 'BRAF']",0.999860981724991,0,0,2
28,Dual hijack model of Vif in HIV infection WP3300,0.11916885777767305,4.3843012704174225,9.326346247950024,"['ELOB', 'ELOC']",0.999860981724991,0,0,2
29,Selenium Micronutrient Network WP15,0.12472255557105974,1.6470890410958905,3.4286852434725263,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOS', 'DIO2', 'SELENOW', 'TXN', 'SELENOK', 'SELENOH']",0.999860981724991,0,0,9
30,Intraflagellar transport proteins binding to dynein WP4532,0.14132624335336547,2.63133514986376,5.148692119542816,"['IFT22', 'DYNLT1', 'DYNLL1']",0.999860981724991,0,0,3
31,Nanomaterial induced apoptosis WP2507,0.14132624335336547,2.63133514986376,5.148692119542816,"['ENDOG', 'BAX', 'CYCS']",0.999860981724991,0,0,3
32,Overview of nanoparticle effects WP3287,0.14132624335336547,2.63133514986376,5.148692119542816,"['COL4A1', 'BAX', 'PTK2']",0.999860981724991,0,0,3
33,Ferroptosis WP4313,0.15292336370845624,1.907663092930332,3.5822448070616932,"['MAP1LC3A', 'GPX4', 'FTH1', 'SAT2', 'FTL']",0.999860981724991,0,0,5
34,Nanoparticle triggered regulated necrosis WP2513,0.15587672335329955,3.507078039927405,6.518570247418294,"['TRADD', 'FTL']",0.999860981724991,0,0,2
35,BDNF-TrkB Signaling WP3676,0.1828525345443435,1.9492929292929293,3.311995416291602,"['NTRK2', 'TRPC6', 'BRAF', 'HRAS']",0.999860981724991,0,0,4
36,Regulation of Actin Cytoskeleton WP51,0.18733951282357064,1.3867842683632157,2.3226316844584542,"['FGF17', 'CHRM3', 'TMSB4X', 'CHRM5', 'BRK1', 'RAC3', 'RRAS2', 'BRAF', 'ARHGAP35', 'PTK2', 'SSH1', 'PAK4']",0.999860981724991,0,0,12
37,7q11.23 copy number variation syndrome WP4932,0.1926619052424285,1.463165905631659,2.409568554021083,"['RFC2', 'ATP5MC2', 'ATP5PO', 'ATP5MC3', 'VPS37B', 'ATP5F1D', 'ACACA', 'ATP5F1E', 'ATP5MC1']",0.999860981724991,0,0,9
38,TP53 network WP1742,0.19366406330139974,2.1923251589464123,3.598987306204047,"['SUMO1', 'GADD45A', 'BAX']",0.999860981724991,0,0,3
39,CAMKK2  Pathway WP4874,0.2271314685420686,1.754,2.599824882095124,"['CHRM3', 'FIS1', 'MAP1LC3A', 'STIM1']",0.999860981724991,0,0,4
40,Copper homeostasis WP3286,0.2271314685420686,1.754,2.599824882095124,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.999860981724991,0,0,4
41,Serotonin and anxiety WP3947,0.2337529773779925,2.50453720508167,3.640320717529829,"['POMC', 'CRH']",0.999860981724991,0,0,2
42,RalA downstream regulated genes WP2290,0.2337529773779925,2.50453720508167,3.640320717529829,"['RAC3', 'HRAS']",0.999860981724991,0,0,2
43,Cytosolic DNA-sensing pathway WP4655,0.2457811247243691,1.566196542311192,2.1978653403581645,"['POLR3GL', 'TRADD', 'POLR2K', 'POLR2L', 'NFKBIB']",0.999860981724991,0,0,5
44,Type 2 papillary renal cell carcinoma WP4241,0.24984068638772342,1.8787465940054495,2.6056934305040085,"['SETD2', 'ELOB', 'ELOC']",0.999860981724991,0,0,3
45,Methionine De Novo and Salvage Pathway WP3580,0.27357440123991406,2.1912431941923773,2.840249241636443,"['AHCY', 'TXN']",0.999860981724991,0,0,2
46,Splicing factor NOVA regulated synaptic proteins WP4148,0.2737408474222098,1.594214876033058,2.0654224390599643,"['KCNQ2', 'GRIK2', 'ANK3', 'STX2']",0.999860981724991,0,0,4
47,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.2737408474222098,1.594214876033058,2.0654224390599643,"['PPP1R14B', 'XBP1', 'MAP1LC3A', 'DDIT3']",0.999860981724991,0,0,4
48,Nephrotic syndrome WP4758,0.2737408474222098,1.594214876033058,2.0654224390599643,"['TRPC6', 'TTC21B', 'PTPRO', 'PAX2']",0.999860981724991,0,0,4
49,The alternative pathway of fetal androgen synthesis WP4524,0.2770745447708179,4.381233000906619,5.623175399113328,['STAR'],0.999860981724991,0,0,1
50,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.2770745447708179,4.381233000906619,5.623175399113328,['MAP1LC3A'],0.999860981724991,0,0,1
51,Mevalonate pathway WP3963,0.2770745447708179,4.381233000906619,5.623175399113328,['PMVK'],0.999860981724991,0,0,1
52,Mitochondrial fatty acid synthesis pathway WP4317,0.2770745447708179,4.381233000906619,5.623175399113328,['ACACA'],0.999860981724991,0,0,1
53,Gastric Cancer Network 2 WP2363,0.27877976085751716,1.7533151680290644,2.239567668048213,"['AHCTF1', 'S100A6', 'COL9A3']",0.999860981724991,0,0,3
54,Glycosylation and related congenital defects WP4521,0.27877976085751716,1.7533151680290644,2.239567668048213,"['DPM2', 'DPM3', 'MPDU1']",0.999860981724991,0,0,3
55,Parkinson's disease pathway WP2371,0.27877976085751716,1.7533151680290644,2.239567668048213,"['ATXN2', 'CYCS', 'PARK7']",0.999860981724991,0,0,3
56,Photodynamic therapy-induced unfolded protein response WP3613,0.27877976085751716,1.7533151680290644,2.239567668048213,"['NARS', 'XBP1', 'DDIT3']",0.999860981724991,0,0,3
57,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3080027641371696,1.6435626702997275,1.9355358616731067,"['MAP1LC3A', 'ACACA', 'FTL']",0.999860981724991,0,0,3
58,ERK Pathway in Huntington's Disease WP3853,0.31328933383782653,1.947570074611817,2.2604046062783434,"['NTRK2', 'HRAS']",0.999860981724991,0,0,2
59,Fatty acid transporters WP5061,0.31328933383782653,1.947570074611817,2.2604046062783434,"['FABP6', 'FABP7']",0.999860981724991,0,0,2
60,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.31328933383782653,1.947570074611817,2.2604046062783434,"['RPS6', 'ACACA']",0.999860981724991,0,0,2
61,IL-18 signaling pathway WP4754,0.31347320936607237,1.161561585960351,1.3474595041199409,"['NRN1', 'TOMM40', 'IMP3', 'CD81', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'GRM7', 'RASA3', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'PTPN7', 'RPS11', 'NOX1', 'ITM2C']",0.999860981724991,0,0,18
62,MET in type 1 papillary renal cell carcinoma WP4205,0.32812897006778435,1.3698532757051864,1.5264940066390296,"['RPL11', 'BRAF', 'HRAS', 'PTK2', 'PAK4']",0.999860981724991,0,0,5
63,SARS-CoV-2 mitochondrial interactions WP5038,0.3373192965072578,1.5467222311267832,1.6808622267505018,"['NDUFB9', 'PHB', 'NOX1']",0.999860981724991,0,0,3
64,VEGFA-VEGFR2 Signaling Pathway WP3888,0.34385073022580687,1.097273998136067,1.1713922666421643,"['RPL5', 'SET', 'TXN', 'RPL10A', 'HDAC9', 'ACACA', 'RPL7', 'RPL18A', 'TMSB4X', 'FAM120A', 'GRB10', 'RPLP2', 'ELOC', 'RPS11', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'FRS2', 'PTK2', 'CYP2C8', 'CYCS', 'RPL27', 'RPL26', 'ALDOA', 'EIF3D', 'PTMA']",0.999860981724991,0,0,31
65,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.34922857090449255,1.3282047040008824,1.397309388650603,"['PSMD8', 'PSMC5', 'PSMD7', 'PSMC1', 'STUB1']",0.999860981724991,0,0,5
66,"Degradation pathway of sphingolipids, including diseases WP4153",0.351193098711855,2.920519794499849,3.0560876014562908,['GLA'],0.999860981724991,0,0,1
67,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3879779050880666,1.2230270682424704,1.1579704507464315,"['RALB', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'BRAF']",0.999860981724991,0,0,6
68,Translation Factors WP107,0.394465810286975,1.2983164983164983,1.2077236192445295,"['EEF1B2', 'EIF2S2', 'EIF3D', 'EIF1']",0.999860981724991,0,0,4
69,Vitamin D-sensitive calcium signaling in depression WP4698,0.39556337261252916,1.3836225440986663,1.2832328009826546,"['GPX4', 'KCNQ2', 'PVALB']",0.999860981724991,0,0,3
70,MAPK Cascade WP422,0.39556337261252916,1.3836225440986663,1.2832328009826546,"['RASA3', 'BRAF', 'HRAS']",0.999860981724991,0,0,3
71,TNF-alpha signaling pathway WP231,0.4015419890913792,1.1798786901339318,1.076572252845474,"['TRADD', 'BAX', 'TXN', 'BTRC', 'HRAS', 'NOX1', 'NFKBIB']",0.999860981724991,0,0,7
72,Biotin Metabolism (including IEMs) WP5031,0.4177187502979283,2.190163191296464,1.9118962101622599,['ACACA'],0.999860981724991,0,0,1
73,Trans-sulfuration pathway WP2333,0.4177187502979283,2.190163191296464,1.9118962101622599,['AHCY'],0.999860981724991,0,0,1
74,Valproic acid pathway WP3871,0.4177187502979283,2.190163191296464,1.9118962101622599,['HSD17B10'],0.999860981724991,0,0,1
75,FTO Obesity Variant Mechanism WP3407,0.4177187502979283,2.190163191296464,1.9118962101622599,['FTO'],0.999860981724991,0,0,1
76,MED and Pseudoachondroplasia genes WP4789,0.4177187502979283,2.190163191296464,1.9118962101622599,['COL9A3'],0.999860981724991,0,0,1
77,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.4177187502979283,2.190163191296464,1.9118962101622599,['PMVK'],0.999860981724991,0,0,1
78,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.42823136989200145,1.4602238354506958,1.2384036355566035,"['CD63', 'CD81']",0.999860981724991,0,0,2
79,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.43368158929485157,1.1841231586454517,0.989269392603224,"['LAMA5', 'TRPC6', 'PTPRO', 'PAX2', 'PTK2']",0.999860981724991,0,0,5
80,Genotoxicity pathway WP4286,0.44234905107815065,1.208526645768025,0.9857420100686535,"['RPS27', 'GADD45A', 'RAPGEF2', 'TRIAP1']",0.999860981724991,0,0,4
81,Corticotropin-releasing hormone signaling pathway WP2355,0.4448378554116283,1.1429080541696366,0.925807449706159,"['POMC', 'STAR', 'CRH', 'BRAF', 'ACACA', 'PTK2']",0.999860981724991,0,0,6
82,p38 MAPK Signaling Pathway WP400,0.452354756672837,1.2515894641235241,0.9928715875548516,"['TRADD', 'DDIT3', 'HRAS']",0.999860981724991,0,0,3
83,Serotonin and anxiety-related events WP3944,0.4774287018772541,1.7519492293744334,1.2952869240024243,['CRH'],0.999860981724991,0,0,1
84,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4774287018772541,1.7519492293744334,1.2952869240024243,['SST'],0.999860981724991,0,0,1
85,Cytosine methylation WP3585,0.4774287018772541,1.7519492293744334,1.2952869240024243,['TET3'],0.999860981724991,0,0,1
86,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4774287018772541,1.7519492293744334,1.2952869240024243,['VEGFB'],0.999860981724991,0,0,1
87,Non-homologous end joining WP438,0.4774287018772541,1.7519492293744334,1.2952869240024243,['DCLRE1C'],0.999860981724991,0,0,1
88,Purine metabolism WP4792,0.4774287018772541,1.7519492293744334,1.2952869240024243,['APRT'],0.999860981724991,0,0,1
89,Alpha 6 Beta 4 signaling pathway WP244,0.4799206277792777,1.1945751795888035,0.8769789089778779,"['LAMA5', 'HRAS', 'PTK2']",0.999860981724991,0,0,3
90,Bladder cancer WP2828,0.4799206277792777,1.1945751795888035,0.8769789089778779,"['DAPK1', 'BRAF', 'HRAS']",0.999860981724991,0,0,3
91,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.499022162588919,1.2513611615245008,0.8698271126325101,"['H2AFJ', 'H2AFZ']",0.999860981724991,0,0,2
92,Modulators of TCR signaling and T cell activation WP5072,0.511764043980159,1.0948863636363637,0.7334551908398446,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.999860981724991,0,0,4
93,Melanoma WP4685,0.5155397388269034,1.0681550855544952,0.707696421648234,"['GADD45A', 'NF1', 'BAX', 'BRAF', 'HRAS']",0.999860981724991,0,0,5
94,Codeine and Morphine Metabolism WP1604,0.5310206676867598,1.4598065880930795,0.9239909100933473,['CYP2C8'],0.999860981724991,0,0,1
95,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.5310206676867598,1.4598065880930795,0.9239909100933473,['CYP2C8'],0.999860981724991,0,0,1
96,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5310206676867598,1.4598065880930795,0.9239909100933473,['RPS6'],0.999860981724991,0,0,1
97,Insulin signaling in adipocytes (normal condition) WP3634,0.5310206676867598,1.4598065880930795,0.9239909100933473,['RPS6'],0.999860981724991,0,0,1
98,Iron metabolism in placenta WP2007,0.5310206676867598,1.4598065880930795,0.9239909100933473,['FTH1'],0.999860981724991,0,0,1
99,Leptin and adiponectin WP3934,0.5310206676867598,1.4598065880930795,0.9239909100933473,['ACACA'],0.999860981724991,0,0,1
100,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5310206676867598,1.4598065880930795,0.9239909100933473,['AHCY'],0.999860981724991,0,0,1
101,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5310206676867598,1.4598065880930795,0.9239909100933473,['PTK2'],0.999860981724991,0,0,1
102,Nanomaterial-induced inflammasome activation WP3890,0.5310206676867598,1.4598065880930795,0.9239909100933473,['NOX1'],0.999860981724991,0,0,1
103,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.532246340729824,1.167816091954023,0.7364818757862789,"['GRB10', 'HRAS']",0.999860981724991,0,0,2
104,Circadian rhythm related genes WP3594,0.5442835571794643,1.0007326007326007,0.6087305530921948,"['KDM5A', 'AHCY', 'STAR', 'KCNH7', 'CAVIN3', 'CRH', 'AVP', 'BTRC', 'RPS27A', 'BTBD9', 'UBA52', 'HCRTR1']",0.999860981724991,0,0,12
105,Androgen receptor signaling pathway WP138,0.5541382289742325,1.010403530895334,0.596482744577125,"['SUMO1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'PTK2']",0.999860981724991,0,0,6
106,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5541382289742325,1.010403530895334,0.596482744577125,"['POMC', 'RPS6KA6', 'RPS6', 'DIO2', 'FRS2', 'HRAS']",0.999860981724991,0,0,6
107,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5541382289742325,1.010403530895334,0.596482744577125,"['RPS6', 'NF1', 'RRAS2', 'BAX', 'BRAF', 'HRAS']",0.999860981724991,0,0,6
108,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5583091892056525,1.0508991825613079,0.612508567609727,"['NTRK2', 'NF1', 'HRAS']",0.999860981724991,0,0,3
109,Unfolded protein response WP4925,0.5639296430405178,1.0947141560798548,0.6270804921371529,"['XBP1', 'DDIT3']",0.999860981724991,0,0,2
110,Nanoparticle-mediated activation of receptor signaling WP2643,0.5639296430405178,1.0947141560798548,0.6270804921371529,"['HRAS', 'PTK2']",0.999860981724991,0,0,2
111,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5639296430405178,1.0947141560798548,0.6270804921371529,"['BRAF', 'HRAS']",0.999860981724991,0,0,2
112,Small cell lung cancer WP4658,0.570102255274068,0.988546475725586,0.5555033508742969,"['LAMA5', 'COL4A1', 'GADD45A', 'CYCS', 'BAX', 'PTK2', 'NFKBIB']",0.999860981724991,0,0,7
113,Non-small cell lung cancer WP4255,0.5735212312856205,0.9950161303664489,0.5531894887786101,"['GADD45A', 'CYCS', 'BAX', 'BRAF', 'HRAS']",0.999860981724991,0,0,5
114,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5791209962140876,1.2511332728921125,0.6834238543191099,['DLL3'],0.999860981724991,0,0,1
115,Biomarkers for pyrimidine metabolism disorders WP4584,0.5791209962140876,1.2511332728921125,0.6834238543191099,['NT5C'],0.999860981724991,0,0,1
116,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5791209962140876,1.2511332728921125,0.6834238543191099,['STAR'],0.999860981724991,0,0,1
117,Genes targeted by miRNAs in adipocytes WP1992,0.5791209962140876,1.2511332728921125,0.6834238543191099,['TMSB4X'],0.999860981724991,0,0,1
118,Homologous recombination WP186,0.5791209962140876,1.2511332728921125,0.6834238543191099,['POLD4'],0.999860981724991,0,0,1
119,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5791209962140876,1.2511332728921125,0.6834238543191099,['BAX'],0.999860981724991,0,0,1
120,DNA Replication WP466,0.5828081839656746,1.0103751833997066,0.5454986943408726,"['POLD4', 'RFC2', 'UBA52']",0.999860981724991,0,0,3
121,Leptin signaling pathway WP2034,0.5920240230636175,0.9728035587908199,0.509951471589473,"['RPS6', 'BAX', 'HRAS', 'ACACA', 'PTK2']",0.999860981724991,0,0,5
122,Sphingolipid pathway WP1422,0.5940386662736181,1.0302124479555888,0.5365458382153145,"['CERS6', 'GBA2']",0.999860981724991,0,0,2
123,Disruption of postsynaptic signaling by CNV WP4875,0.5940386662736181,1.0302124479555888,0.5365458382153145,"['DLG2', 'DLGAP1']",0.999860981724991,0,0,2
124,Ethanol effects on histone modifications WP3996,0.5940386662736181,1.0302124479555888,0.5365458382153145,"['AHCY', 'HDAC9']",0.999860981724991,0,0,2
125,Imatinib and Chronic Myeloid Leukemia WP3640,0.5940386662736181,1.0302124479555888,0.5365458382153145,"['GADD45A', 'SKP2']",0.999860981724991,0,0,2
126,Neural Crest Cell Migration in Cancer WP4565,0.6064248945851791,0.9728529619537793,0.4865961391600136,"['NTRK2', 'TRIO', 'PAK4']",0.999860981724991,0,0,3
127,Tamoxifen metabolism WP691,0.6222919638309309,1.0946282864913872,0.5192324409776926,['CYP2C8'],0.999860981724991,0,0,1
128,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6222919638309309,1.0946282864913872,0.5192324409776926,['IDH3B'],0.999860981724991,0,0,1
129,Cholesterol Biosynthesis Pathway WP197,0.6222919638309309,1.0946282864913872,0.5192324409776926,['PMVK'],0.999860981724991,0,0,1
130,Cysteine and methionine catabolism WP4504,0.6222919638309309,1.0946282864913872,0.5192324409776926,['AHCY'],0.999860981724991,0,0,1
131,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6222919638309309,1.0946282864913872,0.5192324409776926,['PTK2'],0.999860981724991,0,0,1
132,Nanoparticle triggered autophagic cell death WP2509,0.6222919638309309,1.0946282864913872,0.5192324409776926,['MAP1LC3A'],0.999860981724991,0,0,1
133,Nephrogenesis WP5052,0.6222919638309309,1.0946282864913872,0.5192324409776926,['PAX2'],0.999860981724991,0,0,1
134,Pyrimidine metabolism and related diseases WP4225,0.6222919638309309,1.0946282864913872,0.5192324409776926,['NT5C'],0.999860981724991,0,0,1
135,Cell migration and invasion through p75NTR WP4561,0.6225630182256118,0.9728775962895745,0.4610568318906271,"['NTRK2', 'TRIO']",0.999860981724991,0,0,2
136,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6225630182256118,0.9728775962895745,0.4610568318906271,"['SUPT4H1', 'HDAC9']",0.999860981724991,0,0,2
137,Aryl Hydrocarbon Receptor Netpath WP2586,0.629134778887232,0.9380108991825613,0.43468341539926103,"['AIP', 'NF1', 'HRAS']",0.999860981724991,0,0,3
138,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.629134778887232,0.9380108991825613,0.43468341539926103,"['TRADD', 'PIN1', 'NFKBIB']",0.999860981724991,0,0,3
139,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6368840622496663,0.9214354066985646,0.41572184325459205,"['APEX1', 'RPS6', 'BRAF', 'HRAS']",0.999860981724991,0,0,4
140,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6509222228701357,0.9055717372921169,0.3888209151415514,"['NDUFA13', 'COPS6', 'ACAP1']",0.999860981724991,0,0,3
141,MECP2 and Associated Rett Syndrome WP3584,0.6555885571265683,0.8977156177156177,0.3790351814837376,"['SST', 'RPS6', 'TET3', 'NF1']",0.999860981724991,0,0,4
142,Computational Model of Aerobic Glycolysis WP4629,0.6610383237197095,0.9729021859574897,0.4027264994465633,['ALDOA'],0.999860981724991,0,0,1
143,Cori Cycle WP1946,0.6610383237197095,0.9729021859574897,0.4027264994465633,['ALDOA'],0.999860981724991,0,0,1
144,Glutathione metabolism WP100,0.6610383237197095,0.9729021859574897,0.4027264994465633,['GPX4'],0.999860981724991,0,0,1
145,"GPCRs, Class B Secretin-like WP334",0.6610383237197095,0.9729021859574897,0.4027264994465633,['ADGRL2'],0.999860981724991,0,0,1
146,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6610383237197095,0.9729021859574897,0.4027264994465633,['BAX'],0.999860981724991,0,0,1
147,Nucleotide metabolism WP404,0.6610383237197095,0.9729021859574897,0.4027264994465633,['NME2'],0.999860981724991,0,0,1
148,Prolactin Signaling Pathway WP2037,0.6613335070450509,0.893019628233459,0.36926095251891305,"['RPS6', 'PPIB', 'HRAS', 'PTK2', 'NFKBIB']",0.999860981724991,0,0,5
149,Integrin-mediated Cell Adhesion WP185,0.667431629288033,0.8898768176345281,0.3597935016809024,"['RAC3', 'BRAF', 'ITGAE', 'HRAS', 'PTK2', 'PAK4']",0.999860981724991,0,0,6
150,Exercise-induced Circadian Regulation WP410,0.6717795211706924,0.8752951861943687,0.3482143825388477,"['SUMO1', 'GSTP1', 'UCP3']",0.999860981724991,0,0,3
151,p53 transcriptional gene network WP4963,0.6717795211706924,0.8752951861943687,0.3482143825388477,"['SIVA1', 'GADD45A', 'BAX']",0.999860981724991,0,0,3
152,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6749056936433644,0.8754083484573503,0.34419507750756984,"['BAX', 'BRAF']",0.999860981724991,0,0,2
153,Ras signaling WP4223,0.6755840721427783,0.8991799984608939,0.35263831688287006,"['NTRK2', 'GNG10', 'GNG3', 'RALB', 'RASA3', 'NF1', 'RAC3', 'RRAS2', 'RASAL2', 'HRAS', 'PAK4']",0.999860981724991,0,0,11
154,Pancreatic adenocarcinoma pathway WP4263,0.6820353826993191,0.8749544626593807,0.33482209803741886,"['RALB', 'GADD45A', 'RAC3', 'BAX', 'BRAF', 'PAK4']",0.999860981724991,0,0,6
155,Endometrial cancer WP4155,0.6910143117153499,0.8537472283813747,0.31554048816859875,"['GADD45A', 'BAX', 'BRAF', 'HRAS']",0.999860981724991,0,0,4
156,Galanin receptor pathway WP4970,0.6958131859160612,0.8755213055303717,0.3175288714981614,['POMC'],0.999860981724991,0,0,1
157,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6958131859160612,0.8755213055303717,0.3175288714981614,['GRM7'],0.999860981724991,0,0,1
158,ID signaling pathway WP53,0.6958131859160612,0.8755213055303717,0.3175288714981614,['PAX2'],0.999860981724991,0,0,1
159,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6958131859160612,0.8755213055303717,0.3175288714981614,['NRG3'],0.999860981724991,0,0,1
160,MTHFR deficiency WP4288,0.6958131859160612,0.8755213055303717,0.3175288714981614,['CYCS'],0.999860981724991,0,0,1
161,NOTCH1 regulation of endothelial cell calcification WP3413,0.6958131859160612,0.8755213055303717,0.3175288714981614,['DLL3'],0.999860981724991,0,0,1
162,Purine metabolism and related disorders WP4224,0.6958131859160612,0.8755213055303717,0.3175288714981614,['APRT'],0.999860981724991,0,0,1
163,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6958131859160612,0.8755213055303717,0.3175288714981614,['ANAPC11'],0.999860981724991,0,0,1
164,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6987822247140101,0.8336358136721113,0.2987885287660908,"['HRAS', 'PTK2']",0.999860981724991,0,0,2
165,Aryl Hydrocarbon Receptor Pathway WP2873,0.6987822247140101,0.8336358136721113,0.2987885287660908,"['AIP', 'BAX']",0.999860981724991,0,0,2
166,Amyotrophic lateral sclerosis (ALS) WP2447,0.721184696228272,0.7956607820491668,0.26006968938710273,"['TOMM40', 'BAX']",0.999860981724991,0,0,2
167,Histone Modifications WP2369,0.721184696228272,0.7956607820491668,0.26006968938710273,"['SETD2', 'SET']",0.999860981724991,0,0,2
168,ErbB signaling pathway WP673,0.7225345479347224,0.8252785551187186,0.2682073130556461,"['NRG3', 'BRAF', 'HRAS', 'PTK2', 'PAK4']",0.999860981724991,0,0,5
169,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.7270232965042004,0.7958460397263661,0.2537131367366092,['BRAF'],0.999860981724991,0,0,1
170,Apoptosis Modulation by HSP70 WP384,0.7270232965042004,0.7958460397263661,0.2537131367366092,['CYCS'],0.999860981724991,0,0,1
171,Transcriptional cascade regulating adipogenesis WP4211,0.7270232965042004,0.7958460397263661,0.2537131367366092,['DDIT3'],0.999860981724991,0,0,1
172,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7287923718400965,0.7954751878457601,0.2516616213335554,"['BEX3', 'RNF7', 'PTK2']",0.999860981724991,0,0,3
173,Netrin-UNC5B signaling pathway WP4747,0.7287923718400965,0.7954751878457601,0.2516616213335554,"['ARHGEF12', 'DAPK1', 'PTK2']",0.999860981724991,0,0,3
174,Alzheimer's disease WP2059,0.739150500308452,0.7952892561983471,0.2403791399517585,"['PSENEN', 'ATP5MD', 'CYCS', 'HSD17B10']",0.999860981724991,0,0,4
175,3q29 copy number variation syndrome WP4906,0.7459778989927116,0.771998717743228,0.22624140786210872,"['DYNLT1', 'NCBP2', 'DYNLL1']",0.999860981724991,0,0,3
176,22q11.2 copy number variation syndrome WP4657,0.7499976002518901,0.7951029861857888,0.22873941894511524,"['RANBP1', 'MRPL40', 'THAP7', 'DGCR6L', 'PAK4']",0.999860981724991,0,0,5
177,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7550337783299986,0.7294499848896948,0.20497018731243255,['HRAS'],0.999860981724991,0,0,1
178,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7550337783299986,0.7294499848896948,0.20497018731243255,['EXOC6'],0.999860981724991,0,0,1
179,Sphingolipid Metabolism (general overview) WP4725,0.7550337783299986,0.7294499848896948,0.20497018731243255,['CERS6'],0.999860981724991,0,0,1
180,Sphingolipid Metabolism (integrated pathway) WP4726,0.7550337783299986,0.7294499848896948,0.20497018731243255,['CERS6'],0.999860981724991,0,0,1
181,Transcription co-factors SKI and SKIL protein partners WP4533,0.7550337783299986,0.7294499848896948,0.20497018731243255,['NF1'],0.999860981724991,0,0,1
182,Type II diabetes mellitus WP1584,0.7550337783299986,0.7294499848896948,0.20497018731243255,['SURF1'],0.999860981724991,0,0,1
183,Kallmann's Syndrome WP5074,0.7550337783299986,0.7294499848896948,0.20497018731243255,['FRS2'],0.999860981724991,0,0,1
184,MAPK pathway in congenital thyroid cancer WP4928,0.7550337783299986,0.7294499848896948,0.20497018731243255,['BRAF'],0.999860981724991,0,0,1
185,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7550337783299986,0.7294499848896948,0.20497018731243255,['SCO2'],0.999860981724991,0,0,1
186,IL-2 signaling pathway WP49,0.7617766715145137,0.7292044767090139,0.19841788586787953,"['RPS6', 'HRAS']",0.999860981724991,0,0,2
187,Synaptic Vesicle Pathway WP2267,0.76228198491481,0.7498637602179836,0.20354206885153173,"['SLC32A1', 'PARK7', 'STX2']",0.999860981724991,0,0,3
188,Kit receptor signaling pathway WP304,0.76228198491481,0.7498637602179836,0.20354206885153173,"['RPS6', 'GRB10', 'HRAS']",0.999860981724991,0,0,3
189,PPAR signaling pathway WP3942,0.76228198491481,0.7498637602179836,0.20354206885153173,"['FABP6', 'FABP7', 'ME1']",0.999860981724991,0,0,3
190,Acute viral myocarditis WP4298,0.7679468979917915,0.7605533596837944,0.20081247166664576,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.999860981724991,0,0,4
191,Pathways in clear cell renal cell carcinoma WP4018,0.7753875485484014,0.767045001037626,0.1951303512030951,"['SETD2', 'ME1', 'GRB10', 'ALDOA', 'ACACA']",0.999860981724991,0,0,5
192,Proximal tubule transport WP4917,0.7777264488282757,0.7289585225552528,0.18324590307775773,"['SLC7A9', 'SLC6A20', 'ATP6V1F']",0.999860981724991,0,0,3
193,Interleukin-11 Signaling Pathway WP2332,0.7800817820723612,0.6999637023593467,0.17384054643325164,"['RPS6', 'HRAS']",0.999860981724991,0,0,2
194,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7800817820723612,0.6999637023593467,0.17384054643325164,"['STAR', 'HRAS']",0.999860981724991,0,0,2
195,Monoamine GPCRs WP58,0.7800817820723612,0.6999637023593467,0.17384054643325164,"['CHRM3', 'CHRM5']",0.999860981724991,0,0,2
196,Oxidative Damage WP3941,0.7800817820723612,0.6999637023593467,0.17384054643325164,"['GADD45A', 'CYCS']",0.999860981724991,0,0,2
197,Regulation of Microtubule Cytoskeleton WP2038,0.7800817820723612,0.6999637023593467,0.17384054643325164,"['TRIO', 'PARD6A']",0.999860981724991,0,0,2
198,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7801723865700607,0.6732687077202036,0.16713247667824288,['BAX'],0.999860981724991,0,0,1
199,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7801723865700607,0.6732687077202036,0.16713247667824288,['GSTP1'],0.999860981724991,0,0,1
200,Apoptosis WP254,0.7813828612577012,0.744294003868472,0.18360991012872444,"['TRADD', 'CYCS', 'BAX', 'NFKBIB']",0.999860981724991,0,0,4
201,Wnt Signaling Pathway WP363,0.7971411850490446,0.6729722183442691,0.1525785967403446,"['RYK', 'CSNK1G1']",0.999860981724991,0,0,2
202,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7971411850490446,0.6729722183442691,0.1525785967403446,"['DCLRE1C', 'BAX']",0.999860981724991,0,0,2
203,Neural Crest Cell Migration during Development WP4564,0.7971411850490446,0.6729722183442691,0.1525785967403446,"['TRIO', 'PAK4']",0.999860981724991,0,0,2
204,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7971411850490446,0.6729722183442691,0.1525785967403446,"['CYCS', 'CNGB1']",0.999860981724991,0,0,2
205,Integrated breast cancer pathway WP1984,0.8013358879203483,0.7646877848678213,0.1693592914482914,"['GADD45A', 'TRADD', 'NF1', 'BAX', 'BRAF', 'PHB', 'FAU']",0.999860981724991,0,0,7
206,Trans-sulfuration and one-carbon metabolism WP2525,0.8027333300792304,0.6251133272892112,0.13735784686632133,['AHCY'],0.999860981724991,0,0,1
207,Fatty Acid Biosynthesis WP357,0.8027333300792304,0.6251133272892112,0.13735784686632133,['ACACA'],0.999860981724991,0,0,1
208,FOXA2 pathway WP5066,0.8027333300792304,0.6251133272892112,0.13735784686632133,['ACACA'],0.999860981724991,0,0,1
209,GDNF/RET signaling axis WP4830,0.8027333300792304,0.6251133272892112,0.13735784686632133,['PAX2'],0.999860981724991,0,0,1
210,Hippo-Yap signaling pathway WP4537,0.8027333300792304,0.6251133272892112,0.13735784686632133,['MAP4K3'],0.999860981724991,0,0,1
211,One-carbon metabolism WP241,0.8027333300792304,0.6251133272892112,0.13735784686632133,['AHCY'],0.999860981724991,0,0,1
212,Proteoglycan biosynthesis WP4784,0.8027333300792304,0.6251133272892112,0.13735784686632133,['EXT2'],0.999860981724991,0,0,1
213,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8027333300792304,0.6251133272892112,0.13735784686632133,['BAX'],0.999860981724991,0,0,1
214,Senescence and Autophagy in Cancer WP615,0.8096953866155022,0.728465271458902,0.15377695575705594,"['GABARAPL2', 'MAP1LC3A', 'BRAF', 'HRAS', 'GABARAP']",0.999860981724991,0,0,5
215,Complement system WP2806,0.8201593051067497,0.7164486343770045,0.14204072984323712,"['LAMA5', 'FKBP2', 'RPS19', 'CD59', 'TXN']",0.999860981724991,0,0,5
216,16p11.2 distal deletion syndrome WP4950,0.8229807021409636,0.5833786642490179,0.11365530543174429,['CD81'],0.999860981724991,0,0,1
217,Ebstein-Barr virus LMP1 signaling WP262,0.8229807021409636,0.5833786642490179,0.11365530543174429,['TRADD'],0.999860981724991,0,0,1
218,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8229807021409636,0.5833786642490179,0.11365530543174429,['RPS6'],0.999860981724991,0,0,1
219,miRNA targets in ECM and membrane receptors WP2911,0.8229807021409636,0.5833786642490179,0.11365530543174429,['COL4A1'],0.999860981724991,0,0,1
220,Angiogenesis WP1539,0.8411515606016887,0.5468608340888486,0.09459785761792909,['PTK2'],0.999860981724991,0,0,1
221,Striated Muscle Contraction Pathway WP383,0.8411515606016887,0.5468608340888486,0.09459785761792909,['TPM2'],0.999860981724991,0,0,1
222,PDGFR-beta pathway WP3972,0.8411515606016887,0.5468608340888486,0.09459785761792909,['HRAS'],0.999860981724991,0,0,1
223,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.841473523323724,0.6031666562363102,0.10410700488482075,"['TNFSF4', 'RPS6']",0.999860981724991,0,0,2
224,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.841473523323724,0.6031666562363102,0.10410700488482075,"['MAP4K3', 'PAK4']",0.999860981724991,0,0,2
225,MAPK Signaling Pathway WP382,0.841810145108092,0.7770488304056854,0.13380840772668823,"['NTRK2', 'GADD45A', 'RRAS2', 'BRAF', 'FGF17', 'CACNA1I', 'DDIT3', 'NF1', 'RAC3', 'RAPGEF2', 'PTPN7', 'HRAS', 'MAP4K3']",0.999860981724991,0,0,13
226,16p11.2 proximal deletion syndrome WP4949,0.8429682807577324,0.6397288496045723,0.10928228739502249,"['TMEM219', 'ALDOA', 'SEZ6L2']",0.999860981724991,0,0,3
227,EGF/EGFR signaling pathway WP437,0.8489109616612187,0.7277220194647201,0.11920157452629511,"['NDUFA13', 'ATXN2', 'RALB', 'GRB10', 'BRAF', 'NEDD8', 'HRAS', 'PTK2']",0.999860981724991,0,0,8
228,Thermogenesis WP4321,0.8494124334928725,0.659622641509434,0.10765729049861109,"['RPS6KA6', 'RPS6', 'FRS2', 'HRAS']",0.999860981724991,0,0,4
229,TGF-beta Signaling Pathway WP366,0.8502152965789501,0.6988706739526411,0.11340271918479701,"['PARD6A', 'CITED1', 'SUMO1', 'NEDD4L', 'BTRC', 'PTK2']",0.999860981724991,0,0,6
230,NRF2 pathway WP2884,0.8502152965789501,0.6988706739526411,0.11340271918479701,"['FTH1', 'GSTP1', 'ME1', 'TXN', 'SLC6A20', 'FTL']",0.999860981724991,0,0,6
231,DNA damage response WP707,0.8538221132831668,0.6244323342415985,0.09868054363608512,"['GADD45A', 'CYCS', 'BAX']",0.999860981724991,0,0,3
232,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8538221132831668,0.6244323342415985,0.09868054363608512,"['BAX', 'HRAS', 'PTK2']",0.999860981724991,0,0,3
233,Canonical and non-canonical Notch signaling WP3845,0.8574586929553515,0.5146392192416405,0.07914238869530213,['DLL3'],0.999860981724991,0,0,1
234,Estrogen signaling pathway WP712,0.8574586929553515,0.5146392192416405,0.07914238869530213,['BRAF'],0.999860981724991,0,0,1
235,Pregnane X receptor pathway WP2876,0.8574586929553515,0.5146392192416405,0.07914238869530213,['PSMC5'],0.999860981724991,0,0,1
236,Hippo-Merlin Signaling Dysregulation WP4541,0.8582238984785606,0.6896031061259706,0.10543359791588675,"['NTRK2', 'ITGAE', 'HRAS', 'CDH8', 'PTK2', 'PAK4']",0.999860981724991,0,0,6
237,Genes related to primary cilium development (based on CRISPR) WP4536,0.8640148317222104,0.6098472847094607,0.0891385381449923,"['DYNLT1', 'TTC21B', 'DYNLL1']",0.999860981724991,0,0,3
238,miRNA regulation of DNA damage response WP1530,0.8640148317222104,0.6098472847094607,0.0891385381449923,"['GADD45A', 'CYCS', 'BAX']",0.999860981724991,0,0,3
239,Fluoropyrimidine Activity WP1601,0.8720930997379888,0.48599778382189984,0.06651321687444418,['TK1'],0.999860981724991,0,0,1
240,Lipid Metabolism Pathway WP3965,0.8720930997379888,0.48599778382189984,0.06651321687444418,['ACACA'],0.999860981724991,0,0,1
241,Oxidative Stress WP408,0.8720930997379888,0.48599778382189984,0.06651321687444418,['NOX1'],0.999860981724991,0,0,1
242,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8852262229079694,0.46037123634107935,0.0561248000481711,['PPIB'],0.999860981724991,0,0,1
243,GABA receptor Signaling WP4159,0.8852262229079694,0.46037123634107935,0.0561248000481711,['SLC32A1'],0.999860981724991,0,0,1
244,Inflammatory Response Pathway WP453,0.8852262229079694,0.46037123634107935,0.0561248000481711,['LAMA5'],0.999860981724991,0,0,1
245,Phosphoinositides metabolism WP4971,0.8852262229079694,0.46037123634107935,0.0561248000481711,['SBF2'],0.999860981724991,0,0,1
246,Notch Signaling Pathway Netpath WP61,0.8962032333224389,0.5141987829614605,0.05635005161594746,"['PSENEN', 'DLL3']",0.999860981724991,0,0,2
247,Endothelin Pathways WP2197,0.8970119472929591,0.4373073436083409,0.047529228735692736,['RIIAD1'],0.999860981724991,0,0,1
248,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8970119472929591,0.4373073436083409,0.047529228735692736,['HRAS'],0.999860981724991,0,0,1
249,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.8970119472929591,0.4373073436083409,0.047529228735692736,['SBF2'],0.999860981724991,0,0,1
250,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8970119472929591,0.4373073436083409,0.047529228735692736,['NTRK2'],0.999860981724991,0,0,1
251,Folate Metabolism WP176,0.9047875103238802,0.49945553539019966,0.04997310254397939,"['AHCY', 'GPX4']",0.999860981724991,0,0,2
252,White fat cell differentiation WP4149,0.9075883970149031,0.41644001208824416,0.040379818598413206,['DDIT3'],0.999860981724991,0,0,1
253,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9075883970149031,0.41644001208824416,0.040379818598413206,['DDIT3'],0.999860981724991,0,0,1
254,Prion disease pathway WP3995,0.9075883970149031,0.41644001208824416,0.040379818598413206,['PTK2'],0.999860981724991,0,0,1
255,Metapathway biotransformation Phase I and II WP702,0.9103384150880076,0.6234061930783242,0.05856206952046954,"['GSTZ1', 'GSTK1', 'CYP2C8', 'GPX4', 'GSTO1', 'GSTP1']",0.999860981724991,0,0,6
256,Chemokine signaling pathway WP3929,0.9155153798046874,0.6160077145612344,0.054373840195689485,"['GNG10', 'GNG3', 'BRAF', 'HRAS', 'PTK2', 'NFKBIB']",0.999860981724991,0,0,6
257,ATM Signaling Pathway WP2516,0.9170795484373372,0.3974697107063381,0.03440540023961164,['GADD45A'],0.999860981724991,0,0,1
258,Genes controlling nephrogenesis WP4823,0.9170795484373372,0.3974697107063381,0.03440540023961164,['PAX2'],0.999860981724991,0,0,1
259,Heart Development WP1591,0.9170795484373372,0.3974697107063381,0.03440540023961164,['VEGFB'],0.999860981724991,0,0,1
260,PDGF Pathway WP2526,0.9170795484373372,0.3974697107063381,0.03440540023961164,['HRAS'],0.999860981724991,0,0,1
261,Head and Neck Squamous Cell Carcinoma WP4674,0.9193640889259067,0.5240871934604905,0.044061611766819525,"['RPS6', 'CSMD3', 'HRAS']",0.999860981724991,0,0,3
262,Oncostatin M Signaling Pathway WP2374,0.9200005372997697,0.4723598371511257,0.03938584735163421,"['RPS6', 'HRAS']",0.999860981724991,0,0,2
263,Apoptosis Modulation and Signaling WP1772,0.9229747878240694,0.5543434343434344,0.04443248903353396,"['ENDOG', 'TRADD', 'CYCS', 'BAX']",0.999860981724991,0,0,4
264,ATM Signaling Network in Development and Disease  WP3878,0.9255966781369669,0.3801490007489456,0.02939186319911034,['DCLRE1C'],0.999860981724991,0,0,1
265,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9255966781369669,0.3801490007489456,0.02939186319911034,['LAMA5'],0.999860981724991,0,0,1
266,IL17 signaling pathway WP2112,0.9255966781369669,0.3801490007489456,0.02939186319911034,['NFKBIB'],0.999860981724991,0,0,1
267,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.9255966781369669,0.3801490007489456,0.02939186319911034,['BAX'],0.999860981724991,0,0,1
268,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9255966781369669,0.3801490007489456,0.02939186319911034,['STAR'],0.999860981724991,0,0,1
269,Focal Adhesion WP306,0.9265681174953592,0.648432016302502,0.04945442798766694,"['LAMA5', 'COL4A1', 'VEGFB', 'RAC3', 'BRAF', 'HRAS', 'PTK2', 'ARHGAP35', 'PAK4']",0.999860981724991,0,0,9
270,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9267197147937167,0.4598815550673417,0.034998879408000484,"['TMSB4X', 'PTK2']",0.999860981724991,0,0,2
271,Energy Metabolism WP1541,0.9332396626109806,0.3642716832880024,0.025168710114354287,['UCP3'],0.999860981724991,0,0,1
272,Hedgehog Signaling Pathway WP4249,0.9332396626109806,0.3642716832880024,0.025168710114354287,['CSNK1G1'],0.999860981724991,0,0,1
273,Notch Signaling WP268,0.9332396626109806,0.3642716832880024,0.025168710114354287,['DLL3'],0.999860981724991,0,0,1
274,Rett syndrome causing genes WP4312,0.9332396626109806,0.3642716832880024,0.025168710114354287,['BRAF'],0.999860981724991,0,0,1
275,G Protein Signaling Pathways WP35,0.9360557506863354,0.494267646907614,0.032661325512465464,"['GNG10', 'GNG3', 'HRAS']",0.999860981724991,0,0,3
276,Prader-Willi and Angelman Syndrome WP3998,0.9385908514222184,0.4367967332123412,0.027682264967539654,"['POMC', 'FEZ1']",0.999860981724991,0,0,2
277,Tryptophan metabolism WP465,0.9400981453632637,0.34966455122393475,0.021599128716547726,['HSD17B10'],0.999860981724991,0,0,1
278,Breast cancer pathway WP4262,0.9414252061190229,0.575031525851198,0.03470911867013476,"['FGF17', 'GADD45A', 'BAX', 'BRAF', 'HRAS', 'DLL3']",0.999860981724991,0,0,6
279,Pathways affected in adenoid cystic carcinoma WP3651,0.9438185349546306,0.4260988889380727,0.024637617779596763,"['SETD2', 'HRAS']",0.999860981724991,0,0,2
280,Glioblastoma signaling pathways WP2261,0.9453451417884283,0.47619519445132524,0.026764640792015116,"['NF1', 'BRAF', 'HRAS']",0.999860981724991,0,0,3
281,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.946252584487841,0.3361810447032568,0.01857257157672943,['NFKBIB'],0.999860981724991,0,0,1
282,Cardiac Progenitor Differentiation WP2406,0.946252584487841,0.3361810447032568,0.01857257157672943,['MESP1'],0.999860981724991,0,0,1
283,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.946252584487841,0.3361810447032568,0.01857257157672943,['MAP1LC3A'],0.999860981724991,0,0,1
284,Fas ligand pathway and stress induction of heat shock proteins WP314,0.946252584487841,0.3361810447032568,0.01857257157672943,['CYCS'],0.999860981724991,0,0,1
285,Integrated Cancer Pathway WP1971,0.946252584487841,0.3361810447032568,0.01857257157672943,['BAX'],0.999860981724991,0,0,1
286,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9486209017095389,0.41591046581972174,0.021937626535605007,"['IFI27L2', 'HRAS']",0.999860981724991,0,0,2
287,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9517751931429259,0.32369631644336994,0.015999148060440647,['HRAS'],0.999860981724991,0,0,1
288,IL-5 signaling pathway WP127,0.9517751931429259,0.32369631644336994,0.015999148060440647,['RPS6'],0.999860981724991,0,0,1
289,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.956730783447814,0.31210335448776066,0.013805342620315542,['PMVK'],0.999860981724991,0,0,1
290,Development of ureteric collection system WP5053,0.956730783447814,0.31210335448776066,0.013805342620315542,['PAX2'],0.999860981724991,0,0,1
291,One-carbon metabolism and related pathways WP3940,0.956730783447814,0.31210335448776066,0.013805342620315542,['GPX4'],0.999860981724991,0,0,1
292,Oxidation by Cytochrome P450 WP43,0.956730783447814,0.31210335448776066,0.013805342620315542,['CYP2C8'],0.999860981724991,0,0,1
293,G1 to S cell cycle control WP45,0.9570762455786078,0.39692295000824945,0.01741389068882659,"['GADD45A', 'MNAT1']",0.999860981724991,0,0,2
294,Calcium Regulation in the Cardiac Cell WP536,0.9573293402280444,0.5447973588342441,0.023757418929026233,"['CHRM3', 'PKIB', 'GNG3', 'CHRM5', 'ATP1A4', 'RGS6']",0.999860981724991,0,0,6
295,Vitamin A and carotenoid metabolism WP716,0.9611775248816491,0.3013099071497796,0.011930714614196865,['RBP7'],0.999860981724991,0,0,1
296,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9632767977109943,0.5068561271346044,0.018963756284099582,"['NTRK2', 'RPS6', 'FRS2', 'EIF2S2', 'HRAS']",0.999860981724991,0,0,5
297,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9651676242334462,0.29123602296766393,0.010325333095642531,['BAX'],0.999860981724991,0,0,1
298,Pre-implantation embryo WP3527,0.9651676242334462,0.29123602296766393,0.010325333095642531,['DDIT3'],0.999860981724991,0,0,1
299,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9651676242334462,0.29123602296766393,0.010325333095642531,['TRADD'],0.999860981724991,0,0,1
300,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9651995588126508,0.4714004914004914,0.01669719506188772,"['RPS6KA6', 'DIO2', 'HRAS', 'MAP4K3']",0.999860981724991,0,0,4
301,B Cell Receptor Signaling Pathway WP23,0.9662182100835942,0.4290883101800152,0.014745868617652086,"['CD81', 'BRAF', 'HRAS']",0.999860981724991,0,0,3
302,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9680486635811149,0.4952332699147986,0.01608167068938056,"['NTRK2', 'SST', 'AVP', 'ALDOA', 'HDAC9']",0.999860981724991,0,0,5
303,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9687479361801944,0.2818120667972977,0.008947766661711314,['ACACA'],0.999860981724991,0,0,1
304,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9687479361801944,0.2818120667972977,0.008947766661711314,['RPS6'],0.999860981724991,0,0,1
305,Microglia Pathogen Phagocytosis Pathway WP3937,0.9687479361801944,0.2818120667972977,0.008947766661711314,['RAC3'],0.999860981724991,0,0,1
306,Myometrial relaxation and contraction pathways WP289,0.9711916202383551,0.5124290153219758,0.014979062084192005,"['PKIB', 'GNG3', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.999860981724991,0,0,6
307,Glycolysis and Gluconeogenesis WP534,0.9719605119633392,0.27297710788757934,0.007763496491455858,['ALDOA'],0.999860981724991,0,0,1
308,Phosphodiesterases in neuronal function WP4222,0.9719605119633392,0.27297710788757934,0.007763496491455858,['PDE6G'],0.999860981724991,0,0,1
309,Endoderm differentiation WP2853,0.9722201480016998,0.45289256198347105,0.012759346882818276,"['TNRC6C', 'ACACA', 'AHDC1', 'NME1']",0.999860981724991,0,0,4
310,ESC Pluripotency Pathways WP3931,0.9735789085687775,0.40884707084468663,0.010947453070398265,"['FGF17', 'BRAF', 'HRAS']",0.999860981724991,0,0,3
311,Fragile X Syndrome  WP4549,0.9735789085687775,0.40884707084468663,0.010947453070398265,"['NTRK2', 'NF1', 'BRAF']",0.999860981724991,0,0,3
312,Mesodermal commitment pathway WP2857,0.9741413515823352,0.478756911877931,0.012542885806866926,"['EXT2', 'SETD2', 'RPL38', 'ACACA', 'AHDC1']",0.999860981724991,0,0,5
313,Interferon type I signaling pathways WP585,0.9748430909102771,0.2646776010329954,0.006743655310022889,['RPS6'],0.999860981724991,0,0,1
314,Insulin Signaling WP481,0.9759193883810875,0.4735035803299442,0.011541787016475074,"['RPS6KA6', 'XBP1', 'GRB10', 'HRAS', 'MAP4K3']",0.999860981724991,0,0,5
315,TGF-beta Receptor Signaling WP560,0.97742954266423,0.25686630046397524,0.0058640184550223734,['HRAS'],0.999860981724991,0,0,1
316,IL-3 signaling pathway WP286,0.97742954266423,0.25686630046397524,0.0058640184550223734,['HRAS'],0.999860981724991,0,0,1
317,Prostaglandin Synthesis and Regulation WP98,0.97742954266423,0.25686630046397524,0.0058640184550223734,['S100A6'],0.999860981724991,0,0,1
318,Cardiac Hypertrophic Response WP2795,0.9797502633191876,0.24950135992747052,0.0051041923194508195,['HDAC9'],0.999860981724991,0,0,1
319,RANKL/RANK signaling pathway WP2018,0.9797502633191876,0.24950135992747052,0.0051041923194508195,['PTK2'],0.999860981724991,0,0,1
320,Retinoblastoma gene in cancer WP2446,0.9811870905801984,0.3292127521145088,0.006252449229925821,"['H2AFZ', 'SKP2']",0.999860981724991,0,0,2
321,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9818325316371749,0.24254558275410495,0.004446957618579079,['NFKBIB'],0.999860981724991,0,0,1
322,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9818325316371749,0.24254558275410495,0.004446957618579079,['HRAS'],0.999860981724991,0,0,1
323,IL-1 signaling pathway WP195,0.9818325316371749,0.24254558275410495,0.004446957618579079,['NFKBIB'],0.999860981724991,0,0,1
324,DNA damage response (only ATM dependent) WP710,0.982578193679268,0.37902302254867115,0.006661463023581645,"['RAC3', 'BAX', 'HRAS']",0.999860981724991,0,0,3
325,"GPCRs, Other WP117",0.9828585993766001,0.3230826107414129,0.005586103246469186,"['CHRM3', 'ADGRL2']",0.999860981724991,0,0,2
326,Cell cycle WP179,0.9864809056000766,0.3631168634574629,0.0049424959800325845,"['GADD45A', 'SKP2', 'ANAPC11']",0.999860981724991,0,0,3
327,Gastrin signaling pathway WP4659,0.9864809056000766,0.3631168634574629,0.0049424959800325845,"['RPS6', 'HRAS', 'PTK2']",0.999860981724991,0,0,3
328,AMP-activated protein kinase (AMPK) signaling WP1403,0.9868811300222022,0.2238184903642746,0.0029556759085645496,['ACACA'],0.999860981724991,0,0,1
329,Peptide GPCRs WP24,0.9868811300222022,0.2238184903642746,0.0029556759085645496,['HCRTR1'],0.999860981724991,0,0,1
330,Neural Crest Differentiation WP2064,0.9870525340526501,0.30598274270067183,0.003987571684838596,"['HDAC9', 'DLL3']",0.999860981724991,0,0,2
331,Hepatitis B infection WP4666,0.9906775322895595,0.38265734265734264,0.003584042861675832,"['CYCS', 'BAX', 'BRAF', 'HRAS']",0.999860981724991,0,0,4
332,Joubert Syndrome WP4656,0.9915020131369,0.2029138290919058,0.0017317276192696902,['PDE6G'],0.999860981724991,0,0,1
333,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9923763484962348,0.19828154619632407,0.0015174209295379633,['CTSV'],0.999860981724991,0,0,1
334,Endochondral Ossification WP474,0.9923763484962348,0.19828154619632407,0.0015174209295379633,['CTSV'],0.999860981724991,0,0,1
335,Adipogenesis WP236,0.9932089318651395,0.32653269754768394,0.00222506967778767,"['GADD45A', 'CELF1', 'DDIT3']",0.999860981724991,0,0,3
336,AGE/RAGE pathway WP2324,0.9938645160669441,0.18962119121762783,0.0011670015037448108,['CYCS'],0.999860981724991,0,0,1
337,Ciliopathies WP4803,0.994141051101268,0.39167465919058275,0.00230155075043407,"['TBC1D32', 'TTC21B', 'CCNQ', 'CCDC28B', 'CNGB1']",0.999860981724991,0,0,5
338,Spinal Cord Injury WP2431,0.994297100369537,0.31850202698212265,0.001821584198992571,"['COL4A1', 'GADD45A', 'APEX1']",0.999860981724991,0,0,3
339,Ectoderm Differentiation WP2858,0.994297100369537,0.31850202698212265,0.001821584198992571,"['CTNND2', 'CDH8', 'LY6E']",0.999860981724991,0,0,3
340,Pathways Regulating Hippo Signaling WP4540,0.9944846405442603,0.2640103393279437,0.0014601422376790355,"['NTRK2', 'CDH8']",0.999860981724991,0,0,2
341,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9950622927973078,0.18168253248715624,0.0008993172636397641,['HDAC9'],0.999860981724991,0,0,1
342,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9950622927973078,0.18168253248715624,0.0008993172636397641,['RYK'],0.999860981724991,0,0,1
343,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9955704374620239,0.17795622328713898,0.0007900192344929915,['PTPRD'],0.999860981724991,0,0,1
344,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9955998027842459,0.4940246220650489,0.0021786024295793027,"['FGF17', 'LAMA5', 'GNG10', 'GNG3', 'COL4A1', 'RPS6', 'VEGFB', 'ITGAE', 'HRAS', 'PTK2', 'ACACA']",0.999860981724991,0,0,11
345,T-cell receptor (TCR) signaling pathway WP69,0.9964352578857703,0.17094199420475353,0.0006104528268755862,['HRAS'],0.999860981724991,0,0,1
346,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9964352578857703,0.17094199420475353,0.0006104528268755862,['RYK'],0.999860981724991,0,0,1
347,Vitamin D Receptor Pathway WP2877,0.9965011664913996,0.3376522506619594,0.001183460584071861,"['GADD45A', 'TNFSF4', 'S100A6', 'NOX1']",0.999860981724991,0,0,4
348,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9974288982305495,0.28673234122825403,0.000738167388795925,"['COL4A1', 'HRAS', 'DLL3']",0.999860981724991,0,0,3
349,Nuclear Receptors Meta-Pathway WP2882,0.9974316940436104,0.4432285180572852,0.001139810761692882,"['PSMC5', 'FTH1', 'GSTP1', 'AIP', 'ME1', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.999860981724991,0,0,9
350,Toll-like Receptor Signaling Pathway WP75,0.998142043716901,0.15285266657123317,0.0002842577233035425,['NFKBIB'],0.999860981724991,0,0,1
351,PI3K-Akt signaling pathway WP4172,0.9983145620057264,0.4576720740375818,0.0007720286886559384,"['FGF17', 'LAMA5', 'NTRK2', 'GNG10', 'GNG3', 'COL4A1', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS', 'PTK2']",0.999860981724991,0,0,11
352,Wnt signaling WP428,0.9992202229324849,0.13392844689308878,0.00010447507050311912,['RYK'],0.999860981724991,0,0,1
353,Male infertility WP4673,0.9993003387797116,0.13188549135965275,9.230745956482417e-05,['PEX10'],0.999860981724991,0,0,1
354,"GPCRs, Class A Rhodopsin-like WP455",0.9995863815129042,0.2709943181818182,0.00011211144718016278,"['CHRM3', 'CHRM5', 'OR6A2', 'HCRTR1']",0.999860981724991,0,0,4
355,Osteoblast differentiation WP4787,0.9997054612246296,0.11752958761118326,3.4622119833514485e-05,['DLL3'],0.999860981724991,0,0,1
356,Regulation of toll-like receptor signaling pathway WP1449,0.999860981724991,0.10729435993866335,1.4916913722695009e-05,['CUEDC2'],0.999860981724991,0,0,1
